Entrepreneurship Class 12: NCERT Biotechnology Chapter 13 PDF

Entrepreneurship Class 12 is NCERT Biotechnology Chapter 13 — the chapter of the Class 12 Biotechnology textbook that explains the concept of entrepreneurship, the sources of funds for a new venture, how a biotech enterprise is started, and the IPR and biopiracy issues around it.

The chapter runs about 20 printed pages, and the official NCERT PDF is linked right below.

Chapter 13 at a glance: what is inside the file

Use this as a map of the file — where each topic lives, so you can jump straight to what you need instead of scanning the PDF.

The chapter is organised around five main sections:

• 13.1 Concept of Entrepreneurship — the meaning of the term, the three roles an entrepreneur plays, the importance of entrepreneurship, the qualities of an entrepreneur, the entrepreneur–intrapreneur difference, planning and resourcing an enterprise, and the definition of a start-up.
• 13.2 Sources of Funds — the six sources of financing for a new venture collected in Box 3.
• 13.3 Entrepreneurship in Biotechnology — the significance of the biotech entrepreneur, Table 13.1 comparing general and biotech entrepreneurs, and the process of starting a biotech enterprise.
• 13.4 Concept of IPR — patents, plant breeder’s rights, trademarks, copyright and trade secrets, with the TRIPS background in Box 4.
• 13.5 Biopiracy — what biopiracy is, the neem, turmeric and basmati cases, and India’s Traditional Knowledge Digital Library.

Four named boxes support the main text: Box 1 collects short definitions of entrepreneurship from business leaders, Box 2 tells the Dr Krishna Ella / Bharat Biotech story, Box 3 lists the six sources of financing, and Box 4 summarises the rights TRIPS protects.

Table 13.1 compares a general entrepreneur with a biotech entrepreneur, and the chapter closes with a descriptive-and-multiple-choice exercise set. The chapter is text-based — it has no diagrams, so nothing in it needs a figure to be understood.

What this chapter covers, section by section

This is the chapter’s logic in five moves: from the person (the entrepreneur), to the money (sources of funds), to the specialised field (biotechnology enterprise), to the legal protections (IPR), and finally to the abuse those protections exist to stop (biopiracy).

13.1 Concept of Entrepreneurship

The chapter starts with the person because every later idea — funding, enterprise, IPR — belongs to the entrepreneur. The word comes from the French ‘entreprendre’, meaning ‘to undertake’. An entrepreneur is someone who starts an activity because they can see a business opportunity in it, then organises the resources the enterprise needs and accepts the accompanying risk.

That definition carries straight into the importance of entrepreneurship: entrepreneurs create capital by bringing resources together, create employment that raises the standard of living and purchasing power, and help develop the whole community by spreading opportunity across small units. Self-employment, the chapter adds, empowers an individual and drives social change.

13.2 Sources of Funds

An idea needs money before it becomes an enterprise, which is why the chapter asks where the money comes from. Box 3 names six sources — from the founder’s own savings to bank loans — each suited to a different stage of the venture. The full list sits in the key concepts section below.

13.3 Entrepreneurship in Biotechnology

Biotechnology is pure science that turns into commerce the moment its products reach a market, and that merger creates a discipline of its own. The chapter defines biotechnology entrepreneurship as building and sustaining an enterprise on biotechnological innovation — the amalgamation of science and business.

It then compares biotech and general entrepreneurs in Table 13.1 and lays out the six steps of starting a biotech enterprise.

13.4 Concept of IPR

Modern biotech innovation is commercially valuable, and commercially valuable work needs legal protection. The chapter introduces Intellectual Property Rights and the TRIPS Agreement that gives them international reach, then runs through the five forms of IPR a biotech firm typically needs: patent, plant breeder’s right, trademark, copyright and trade secret.

13.5 Biopiracy

The chapter ends with the failure the IPR system exists to prevent. Biopiracy is the commercial exploitation of biochemicals or genetic materials that occur naturally — typically built on traditional knowledge that was never compensated. The three landmark cases (neem, turmeric, basmati) and India’s TKDL response close the chapter.

The book itself closes the chapter with a one-page SUMMARY that recaps these five sections — that recap is rebuilt in plainer words further down this page.

Key concepts in Entrepreneurship Class 12

This is the core of the chapter — the definitions and distinctions the exercises keep returning to. Read it once and the rest of the chapter falls into place.

What an entrepreneur is, and the three roles

Everything in the chapter hangs on this definition, so get it exact. An entrepreneur is someone who starts an activity because they foresee a business opportunity in it, organises the resources the enterprise needs and bears the risk of it all. The French root ‘entreprendre’ means ‘to undertake’ — which is exactly what the entrepreneur does.

• Innovator — brings new products into the market.
• Organiser — arranges the factors of production to take advantage of the opportunity.
• Risk bearer — shoulders all the uncertainties of the venture.

Why three roles? Because they describe one person across the life of a venture: spotting something new, building the business around it, and carrying the uncertainty while it grows.

The six qualities of a successful entrepreneur

The chapter lists six qualities shared by successful entrepreneurs. They come up in Question 2 of the exercises and are easy to confuse with the three roles, so learn them as a set.

1. Initiative — taking action at the right time to launch a venture.
2. Knowledge and skill — understanding the industry, economy, consumer choices and technology.
3. Risk taker — accepting short-term risks for the long-term prospect of success.
4. Adaptability — monitoring the business environment and adjusting to its changes.
5. Self-confidence — trusting your own decisions; the belief that makes risk-taking possible.
6. Wealth creator — translating great ideas into commercial success.

Mnemonic: “I Knew Risk — Adapt, Stay Wealthy” — Initiative, Knowledge, Risk taker, Adaptability, Self-confidence, Wealth creator. Each word’s first letter keys to a quality in order.

The chapter’s own case is Dr Krishna Ella of Bharat Biotech (Box 2). He shows the qualities in action: initiative in leaving a village in Tamil Nadu to study and eventually build a vaccine company; adaptability in shifting from plant pathology to human and yeast molecular biology; and wealth creation through Bharat Biotech and COVAXIN, India’s first COVID-19 vaccine.

Planning and resourcing an enterprise

A business idea becomes a sustainable venture only through planning and resourcing (section 13.1.4). These are two halves of one job: planning decides what the business will do, resourcing supplies what it needs to do it.

• Planning — setting clear objectives, defining the business model, analysing the market, and outlining strategies for operations, marketing and growth; it also means identifying risks and preparing contingency plans.
• Resourcing — securing financial capital, skilled personnel, technology, raw materials and infrastructure, while checking availability, sourcing options and cost-effectiveness against the enterprise’s goals.

What legally counts as a start-up

‘Start-up’ here is a legal label with a definition, not just a buzzword: recognition under the Startup India programme follows the criteria in G.S.R. notification 127 (E) of 16 January 2019.

• The entity must be incorporated as a private limited company, or registered as a partnership firm or limited liability partnership.
• Turnover must be below INR 100 crore in any previous financial year.
• An entity counts as a start-up for up to 10 years from incorporation.
• It must work towards innovation or improvement of existing products, services or processes, with the potential to generate employment and create wealth.

One important exclusion: an entity formed by splitting up or reconstructing an existing business is not a start-up. The definition matters because recognition is the gateway to the programme’s support, including the government grants and subsidies listed among the financing sources.

The six sources of financing a new venture

Box 3 names six sources of financing. The exam answer is the list with one line on each — and it helps to know which stage each source fits, because that is the logic behind the list.

The biotech enterprise: Table 13.1 and the six start-up steps

Biotechnology is pure science that becomes commerce when its results are sold — and that merger is why a biotech enterprise behaves differently from an ordinary business. First-time founders, the chapter says, are caught between academic skill and business judgement.

Table 13.1: General entrepreneur vs biotech entrepreneur

The chapter’s only comparison table sets the two side by side. The first three rows are identical; the differences begin at the gestation period.

Read the divergence as one idea: biotech ventures need far more money, take far longer, and add scientific uncertainty on top of business uncertainty — while demanding deep academic expertise and clearing a heavy regulatory framework. Those differences are exactly why the chapter gives biotech companies a separate six-step process.

The six steps of starting a biotech enterprise

Section 13.3.3 turns the roadmap into six steps. The book opens the process with Louis Pasteur’s line that chance only favours the prepared mind — the steps exist to replace chance with preparation.

1. Need assessment — verify there is real market demand for the product, confirm the technology is protected by intellectual property, and secure the IP rights and assurances of inventors and key personnel.
2. Identification of founders and key personnel — find like-minded people with expertise in diverse disciplines; this team is indispensable to the idea’s success.
3. Getting a legal expert — the legal advisor is a key partner who guides the promoter through corporate and business issues at every stage.
4. Incorporation as a Private Limited Company — registering under the Companies Act 2013 suits biotech start-ups because the business demands high capital and a long gestation period.
5. Designing a marketing and business strategy — the plan must state the market problem, how the product solves it, expected revenue, use of funds and expected return on investment; without it, no money is raised.
6. Focus on technology development after seed capital is raised — the product is the pivot of a biotech enterprise, so consistent innovation in it keeps market sentiment positive.

One-sentence chain: “Check the market need, bring the founders together, hire a legal expert, incorporate the company, design the marketing strategy, and only then focus on technology development.” Hold the order and you can write the whole of Question 8 from memory.

IPR in biotechnology: patents, trademarks, copyright and the rest

The chapter moves from building the enterprise to protecting it. Modern biotech innovation is a commercial asset, and its proprietary aspect is the key feature: in the past such innovations came from publicly funded laboratories, but today they sit protected within the legal framework of Intellectual Property Rights.

The TRIPS Agreement of the World Trade Organisation gives IPR the authority to be enforced internationally, and India is a signatory. Box 4 summarises the categories TRIPS protects: copyright for authors, computer programmes and performers; trademarks; geographical indications; industrial designs; patents; plant breeders’ and farmers’ rights; biological diversity; layout designs of integrated circuits; and undisclosed business information.

Five of these matter most to a biotech enterprise, and the chapter takes them one by one.

Patent

Patents protect inventions — new, useful, non-obvious products or processes — and they are the protection a biotech firm cares about most.

The legal history matters for exam answers. The Patents Act 1970, with the Patents Rules 1972, came into force on 20 April 1972 on the basis of the Ayyangar Committee Report, and initially allowed only process patents for drugs, medicines, food and chemicals.

After India joined TRIPS, the 2005 Amendment deleted Section 5 of the Act, opening the door to product patents in biotechnology, chemicals and pharmaceuticals.

The three central criteria are novelty, non-obviousness (inventive step) and utility. The invention must also avoid the negative list in Section 3 of the Act, and biotech inventions involving DNA must not be contrary to public order and morality. The distinction that matters most: only inventions are patentable in India — discoveries are not.

Plant breeder’s right

Where patents protect inventions, plant breeder’s rights protect new plant varieties. The right gives exclusive commercial control for about 20–25 years over a new variety or its reproductive material, stopping anyone from growing or selling it without permission.

To qualify, the variety must be novel, distinct, uniform and stable, and two exceptions keep the right fair: research use, and a farmer saving seed for replanting.

Trademark

A trademark identifies the source of goods or services, so customers can tell one seller from another. Section 2 (zb) of the Trademark Act 1999 defines a mark that can be represented graphically and distinguishes one person’s goods or services from others’; it may include the shape of goods, packaging or a combination of colours.

The two essential ingredients for registration are exactly those two qualities: graphical representability and the capacity to distinguish.

Copyright

Copyright is a bundle of rights given to creators of literary, dramatic, musical and artistic works, plus producers of cinematograph films and sound recordings. It includes the rights of reproduction, communication to the public, adaptation and translation.

What students usually miss is the list of exclusions: research or private study, criticism or review, reporting current events, judicial proceedings, an amateur performance to a non-paying audience, and certain sound recordings of literary, dramatic or musical works do not infringe copyright.

Trade secret

A trade secret is confidential business information — a formula, process, design or method — that gives a company a competitive advantage because it stays secret. The crucial difference from every other IPR here: trade secrets are not registered.

Protection depends on the company’s own confidentiality measures, mainly non-disclosure agreements and secure information practices, enforced through contract and tort law. TRIPS requires members to protect undisclosed information of commercial value where reasonable steps have kept it secret, and remedies come through civil suits — damages or injunctions.

Keep the five forms apart with one comparison table:

Biopiracy: neem, turmeric, basmati and TKDL

Biopiracy is the wrong the IPR system exists to prevent: taking naturally occurring biochemicals or genetic material and exploiting it commercially. Section 13.5 defines it as the commercial exploitation of biochemicals or genetic materials that occur naturally, where indigenous people’s traditional understanding of the natural environment is passed on from one generation to the next.

The traditional knowledge under threat clusters in farming or agriculture, medicinal plants and varieties of food crops.

The chapter’s three landmark cases are best revised through the same four questions: what was taken, who patented it, who challenged it, and how it ended.

Note that the endings differ — only basmati ended in partial revocation, so be precise. India’s institutional answer is the Traditional Knowledge Digital Library (TKDL): a pioneering initiative to prevent the misappropriation of the country’s traditional medicinal knowledge at international patent offices. Its beginning dates back to the effort that got the turmeric wound-healing patent revoked at the USPTO.

Definitions at a glance

The chapter’s key terms cluster in two groups — the concept and financing terms arrive early, the legal terms from 13.4 onward. This table pulls them into one place for a last-minute scan.

Common mistakes students make in this chapter

This chapter trips students because its terms sit close together and its legal distinctions are one word apart. Name the error before you make it:

• Treating entrepreneur and intrapreneur as the same thing. Both value innovation and creativity, but an intrapreneur is an employee of an organisation who promotes innovation inside it, while an entrepreneur starts the venture and bears its risk. The risk-bearer is the entrepreneur.
• Writing ‘discovery’ where patent law requires ‘invention’. In India only inventions are patentable; discoveries are not. The three criteria — novelty, non-obviousness, utility — apply to inventions.
• Assuming every IP right is registered. Trade secrets are never registered; their protection rides on confidentiality, NDAs and contract law. Registration is the rule for patents, trademarks and plant breeder’s rights, not for trade secrets.
• Mixing up the biopiracy cases. Neem was revoked by the European Patent Office in 2000; turmeric was revoked by the USPTO in 1997 after CSIR’s challenge; basmati was only partially revoked. Use the culprit and the year as the hook: Grace/USDA (neem, 2000), Mississippi researchers (turmeric, 1997), RiceTec (basmati, partial).
• Forgetting the Section 3 negative list. A complete patent answer names the three criteria and then adds that the invention must not fall in the negative list of Section 3 of the Patents Act — and that biotech DNA inventions must not be contrary to public order and morality.
• Miscounting the financing sources. The chapter itself points two ways: Box 3 is headed ‘Six sources of financing’ and lists six, while the chapter’s SUMMARY says ‘seven sources’ and then lists the same six. The answer to use is six — personal investment, venture capital, angel investors, business incubators, government grant and subsidy, and bank loans — because the named list in both places contains six items.

Using the exercises to revise

First, the honest caveat: textbook contents and the examinable syllabus are not always identical, so check the current official CBSE syllabus for what is examinable — and nothing on this page promises which questions will appear in any exam.

The descriptive questions at the start of the exercise set follow the chapter’s own order, so one good revision pass is: read a section, then answer its matching question.

The remaining questions are multiple choice, and most test recall of a definition or a distinction rather than reasoning. Three worked examples show the method — read why the wrong options are wrong, then try the rest yourself.

Worked example: what financing do angel investors provide?

The question offers debt, equity, stock sales or none of the above. The answer is equity: an angel invests money, ideas and experience into a promising start-up and tends to finance the early stages of business — an ownership stake, not a loan.

‘Debt’ fails because debt is borrowed money that must be repaid; ‘stock sales’ fails because a start-up angel is not selling shares to the public; ‘none of the above’ fails because equity is exactly the match.

Worked example: what cannot be covered by copyright?

The options are computer software, computer hardware, poems and songs, and models and sculpture. The odd one out is computer hardware.

Copyright protects creative expression — the chapter’s list is literary, dramatic, musical and artistic works, plus films and sound recordings. Software counts as protected work, poems and songs are literary and musical works, and models and sculpture are artistic; hardware is a physical device, not a creative work, so it cannot be covered by copyright.

Worked example: which initiative protects India’s traditional medicinal knowledge?

The options are TKDL, the National Digital Library of India, the Digital Library of Open Access Books and the Universal Digital Library. The answer is TKDL.

Section 13.5 defines TKDL as the initiative to prevent misappropriation of India’s traditional medicinal knowledge at international patent offices. The other three are general libraries of learning resources, open-access books and digitised texts — none of them exists to stop international patents on traditional knowledge.

Quick key for the remaining multiple choice items:

Revision summary in one page

This is the chapter’s own SUMMARY rebuilt in plainer words — the points NCERT chose to remember, compressed for the night before the exam.

Related chapters and resources

This listing is maintained for the 2026-27 academic session using the NCERT textbook information available to us. NCERT remains the authority for confirming the latest edition.

This chapter commercialises the science covered earlier in the book, so the natural next step is the previous chapter, Recent Innovations in Biotechnology. For the whole subject, the NCERT Class 12 Biotechnology book page is where you can move between chapters of the textbook.

From here you can go up to the Class 12 hub or the main CBSE notes section. The authoritative source for every textbook is ncert.nic.in, where the official chapter PDFs live, and the current CBSE syllabus — for what is examinable — is on cbse.gov.in.

Sources and data verification

• This page describes the NCERT Class XII Biotechnology textbook, chapter 13 ‘Entrepreneurship’, as published on ncert.nic.in. Every concept, case and definition above is drawn from that official edition.
• It covers this one chapter of the Class 12 Biotechnology book only — not the Class 11 Biotechnology book and not the Biology textbook.
• Textbook contents and the examinable syllabus are not always identical — check the current official CBSE syllabus for what is examinable. This page is maintained for the current academic session against the NCERT edition available on ncert.nic.in, and it makes no promise about which questions appear in any exam.
• NCERT settles textbooks, editions and PDFs; CBSE settles curriculum, syllabus and examinations.

Reference: NCERT Class 12 Biotechnology textbook, chapter 13, official edition on ncert.nic.in.

Frequently asked questions

What is the difference between an entrepreneur and an intrapreneur?

An entrepreneur takes the risk of starting a business venture to earn profit — they foresee opportunities, organise the factors of production and bear the uncertainties. An intrapreneur is an employee of an organisation who promotes innovation among its employees. Both value innovation and creativity, but the entrepreneur carries the venture’s risk while the intrapreneur works inside an existing organisation.

What are the three roles of an entrepreneur?

The three roles are innovator, organiser and risk bearer. As innovator, the entrepreneur brings new products to market; as organiser, they arrange the factors of production to exploit a market opportunity; as risk bearer, they shoulder the uncertainties of the venture.

What are the three criteria for a patent to be granted in India?

Novelty, non-obviousness (inventive step) and utility. The invention must also avoid the negative list in Section 3 of the Patents Act, and biotech inventions involving DNA must not be contrary to public order and morality. Only inventions are patentable — discoveries are not.

What is biopiracy and what are the neem, turmeric and basmati cases?

Biopiracy is the commercial exploitation of biochemicals or genetic materials that occur naturally, usually on the back of traditional knowledge that was never compensated.

In the neem case, a patent on neem oil as a pesticide was revoked by the European Patent Office in 2000. In the turmeric case, a US patent on turmeric for wound healing was revoked by the USPTO in 1997 after CSIR’s challenge. In the basmati case, RiceTec’s US patent on basmati strains was only partially revoked.

What are the sources of funds for a new venture named in this chapter?

Box 3 names six sources: personal investment, venture capital, angel investors, business incubators, government grant and subsidy, and bank loans.

Personal investment comes first and proves the founder’s commitment; angels fund early stages; venture capital suits high-growth, technology-driven companies; incubators support high-tech ventures through development; government agencies give grants and subsidies; bank loans are the most common source and need a strong business plan.

What is the Traditional Knowledge Digital Library (TKDL)?

TKDL is a pioneering initiative of India to prevent the misappropriation of the country’s traditional medicinal knowledge at international patent offices. Its origin lies in the Indian effort that got the turmeric wound-healing patent revoked at the USPTO.